Lancôme has launched the Absolue Longevity MD collection , a new skincare line designed to address the biological age of the skin rather than chronological years. the range utilizes longevity science and AI-driven diagnostics to offer age-specific protocols for different life stages.

How Mitopure by Timeline targets mitochondrial decay

At the center of the new collection is Mitopure by Timeline, a breakthrough ingredient derived from a popular longevity supplement. According to the report, this marks the first time a major global beauty brand has integrated Urolithin A—the active component of Mitopure—into a skincare line. The ingredient is intended to support mitochondrial health, focusing on the "powerhouses" of skin cells that drive energy production and cellular renewal.

As skin ages, mitochondrial function typically declines, which leads to the visible signs of aging.. By targeting these cellular structures, Lancôme aims to help skin maintain vitality and resilience over the long term, moving beyond the traditional approach of simply treating surface-level wrinkles after they appear.

From the £150 Intercept Cream to the £160 Reset Serum

The Absolue Longevity MD range is segmented into three distinct protocols: Anticipate, Intercept, and Reset. The Anticipate line is tailored for those under 35 to prevent early signs of aging. For users aged 35 to 55, the Intercept protocol focuses on correcting emerging signs; as reported by the Daily Mail, the Absolue Longevity MD Intercept The Cream (£150) is clinically proven to deliver up to 76 per cent tightened skin and accelerate surface cell renewal.

For consumers aged 55 and older, the Reset protocol aims to restore firmness and recovery. The Absolue Longevity MD Reset The Serum (£160) claims to provide up to 41 per cent tightened skin and a 22 per cent increase in skin firmness. This tiered pricing and formulation strategy allows Lancôme to market a specific biological solution for every decade of adulthood.

Cell BioPrint’s AI analysis at Harrods London

To guide consumers through these protocols, Lancôme is introducing Cell BioPrint, an AI-powered skin analysis tool. This technology assesses the biological age of a user's skin to recommend whether they should prioritize the Anticipate, Intercept, or Reset routines, or perhaps a blend of several approaches based on their evolving needs.

Currently, the Cell BioPrint tool is available exclusively at Harrods in London. This exclusive rollout suggests a strategy of positioning the technology as a high-end, bespoke service, blending luxury retail with data-driven dermatological analysis.

The migration of longevity supplements into luxury creams

The launch of the Absolue Longevity MD range reflects a broader shift in the beauty industry toward "longevity science." For years, the luxury market focused on anti-aging—a reactive approach to hiding wrinkles. Now, the trend is shifting toward longevity, which borrows from the bio-hacking community's obsession with cellular health and lifespan extension.

By incorporating ingredients like Urolithin A, Lancôme is aligning its brand with the wellness movement that treats the body as a system to be optimized. This transition suggests that the future of high-end skincare will rely less on traditional moisturizers and more on ingredients that claim to alter the skin's biological trajectory.

The missing data on Mitopure's long-term efficacy

Despite the impressive percentage claims regarding skin tightening, several questions remain. The source does not specify the size of the clinical trials used to reach the "+76 per cent" tightening figure, nor does it clarify if these results were measured against a placebo or a standard moisturizer.

Furthermore, it remains unclear whether "biological age" is being measured by a standardized medical metric or a proprietary Lancôme algorithm. Without independent verification of how Cell BioPrint calculates this age, consumers are relying entirely on the brand's internal definitions of cellular health.